| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 01/13/2004 | US6677142 Chain extension of glucosyl group acceptor with sucrose in presence of amylosucrase and fructose; low polydispersity |
| 01/13/2004 | US6677137 Preferential nucleotide sequences for use in prevention of bacterial, viral and protozoan infection; for use in treatment of nervous system disorders |
| 01/13/2004 | US6677134 Generation of zeaxanthin by fermentation; obtain cells, transform with vector, express vector, incubate with farnesyl pyrophosphate, recover zeaxanthin |
| 01/13/2004 | US6677130 Mitogen-activated protein kinase p38-2 and methods of use therefor |
| 01/13/2004 | US6677115 Protein activity screening of clones having DNA from uncultivated microorganisms |
| 01/13/2004 | US6676948 Haemophilus adherence and penetration proteins |
| 01/13/2004 | US6676943 Human complement C3-degrading protein from Streptococcus pneumoniae |
| 01/12/2004 | CA2403235A1 Modulation of cytochrome p450 reductase activity |
| 01/08/2004 | WO2004003817A1 Mutational profiles in hiv-1 protease correlated with phenotypic drug resistance |
| 01/08/2004 | WO2004003224A1 Electrochemical sensing using an enzyme electrode |
| 01/08/2004 | WO2004003216A2 Sterilization of a fermentation medium comprising hydrolysed n-source |
| 01/08/2004 | WO2004003210A2 Selective functionalization of hydrocarbons with isolated oxygenases and mediator based regeneration |
| 01/08/2004 | WO2004003208A2 Stress tolerant plant |
| 01/08/2004 | WO2004003206A1 Novel transglucuronidases and genes tehreof |
| 01/08/2004 | WO2004003205A1 Hansenula polymorpha mutant strains with defect in outer chain biosynthesis and the production of recombinant glycoproteins using the same strains |
| 01/08/2004 | WO2004003204A1 Hansenula polymorpha yapsin deficient mutant strain and process for the preparation of recombinant proteins using the same |
| 01/08/2004 | WO2004003195A1 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 01/08/2004 | WO2004003194A2 Protein glycosylation modification in pichia pastoris |
| 01/08/2004 | WO2004003193A1 Novel pla2 enzyme, it's antibody, enzyme inhibitor and use and the preparation methods thereof |
| 01/08/2004 | WO2004003191A1 Regulation of human map kinase kinase kinase |
| 01/08/2004 | WO2004003190A1 Polypeptide identified as a cytochrome p450 |
| 01/08/2004 | WO2004003189A2 Regulation of human phospholipase c-like protein |
| 01/08/2004 | WO2004003188A2 Stabilization of granules |
| 01/08/2004 | WO2004003187A2 Mpg added to fermentation |
| 01/08/2004 | WO2004003186A2 Subtilases and subtilase variants having altered immunogenicity |
| 01/08/2004 | WO2004003185A2 Plant deoxyribonucleoside kinase enzymes and their use |
| 01/08/2004 | WO2004003169A2 Recombinant genes for polyketide modifying enzymes |
| 01/08/2004 | WO2004003162A2 Enzymes |
| 01/08/2004 | WO2004003139A2 Modified shine-dalgarno sequences and methods of use thereof |
| 01/08/2004 | WO2004003135A2 Selective cloning of homoduplex nucleic acids |
| 01/08/2004 | WO2004003012A2 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 01/08/2004 | WO2004003004A1 Compositions and methods involving inhibiting or enhancing the deubiquitylation of an enzyme |
| 01/08/2004 | WO2004002509A2 Use of casein peptides for treating hypertension |
| 01/08/2004 | WO2004002416A2 Methods and materials for treating human papillomavirus infections |
| 01/08/2004 | WO2004002408A2 Cancer vaccine containing cross-species epitopes of telomerase reverse transcriptase |
| 01/08/2004 | WO2004002215A2 Genetic manipulation of condensed tannins |
| 01/08/2004 | WO2003089640A3 Biofertilizer for plants based on rhizobium bacteria having an improved nitrogen fixing capacity |
| 01/08/2004 | WO2003085090A3 A human ribonucleotide reductase m2 subunit |
| 01/08/2004 | WO2003080827A3 Granules with filamentous coatings |
| 01/08/2004 | WO2003078614A3 Gntiii (udp-n-acethylglucosamine:beta-d mannoside beta (1,4)-n-acethylglucosaminy ltransferase iii) expression in plants |
| 01/08/2004 | WO2003075844A3 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43 |
| 01/08/2004 | WO2003060478A3 Methods and compositions for assaying homocysteine |
| 01/08/2004 | WO2003054194A3 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 01/08/2004 | WO2003031570A3 METHOD FOR CLONING AND EXPRESSION OF BseRI RESTRICTION ENDONUCLEASE AND BseRI METHYLASE IN E. COLI |
| 01/08/2004 | WO2003022224A3 Cox-2 function and wound healing |
| 01/08/2004 | WO2002092623A8 INHIBITORS OF RECEPTOR ACTIVATOR OF NF-κB AND USES THEREOF |
| 01/08/2004 | WO2002066654A3 Drug metabolizing enzymes |
| 01/08/2004 | WO2002066622A3 Method of generating diversity into lipolytic enzymes and lipolytic enzyme genes |
| 01/08/2004 | WO2002064797A3 Mitochondrial topoisomerase i |
| 01/08/2004 | WO2002061059A3 Carbohydrate metabolism enzymes |
| 01/08/2004 | WO2002055110A3 Methods for treating blood coagulation disorders |
| 01/08/2004 | WO2002053594A3 Inhibitors of memapsin 2 and use thereof |
| 01/08/2004 | WO2002051989A3 Human 4-nitrophenylphosphatase |
| 01/08/2004 | WO2002050250A3 Signal-1/signal-2 bifunctional peptide inhibitors |
| 01/08/2004 | WO2002048397A3 Regulation of human adenylate cyclase, type vii |
| 01/08/2004 | WO2002046460A3 Method for detecting risk of atherosclerosis |
| 01/08/2004 | WO2002038613A3 Modified recombinase |
| 01/08/2004 | WO2002036782A3 Novel glyphosate n-acetyltransferase (gat) genes |
| 01/08/2004 | WO2001079524A3 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof |
| 01/08/2004 | WO2000052135A3 Engineering intracellular sialylation pathways |
| 01/08/2004 | US20040006795 Increasing flavonoid production in soy bean plants; food processing; nutrients; beverages |
| 01/08/2004 | US20040006794 Bioengineering cotton fiber properties |
| 01/08/2004 | US20040006792 Soybean seeds exhibiting oil composition which comprises varying concentrations of oleic acid, linoleic acid, linolenic acid and saturated fatty acids; vegetable oils |
| 01/08/2004 | US20040006791 Endoglucanase gene promoter upregulated by the root-knot nematode |
| 01/08/2004 | US20040006784 Methods and compositions for producing plants and microorganisms that express feedback insensitive threonine dehydratase/deaminase |
| 01/08/2004 | US20040006779 Antibodies against gene products related to werner's syndrome |
| 01/08/2004 | US20040006777 Comprises nucleotide sequences coding cytoplasmic phosphatases for treating and preventing tumors and metastasis; immunosuppressant |
| 01/08/2004 | US20040006219 Comprises membrane protein for diagnosis, prevention and treatment of cell proliferative and inflammatory disorders |
| 01/08/2004 | US20040006211 Comprises membrane protein for diagnosis, prevention and treatment of cell proliferative and inflammatory disorders |
| 01/08/2004 | US20040006206 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/08/2004 | US20040006026 For use as antibiotics, in therapy of infectious diseases |
| 01/08/2004 | US20040006016 Isolated nucleic acids molecules, designated 27875, 22025, 27420, 16319, 55092 and 10218 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors and fusion proteins |
| 01/08/2004 | US20040006005 Treating conditions of insulin resistance, hyperglycemia and/or diabetes. In a broad embodiment, the methods comprise the step of administering to a mammal in need of treatment a therapeutically effective amount of an ILK inhibitor. |
| 01/08/2004 | US20040005713 Mobilization of viral genomes from T-DNA using site-specific recombination systems |
| 01/08/2004 | US20040005695 Culturing genetically engineered escherichia and/or klebsiella coding phytase and/or amylase and recovering enzymatic polypeptides |
| 01/08/2004 | US20040005692 Comprises nucleotide sequences coding amidase (AMDS) for use as diagnostic tool in genetic engineering |
| 01/08/2004 | US20040005691 Comprises genetically engineered beta-site amyloid precursor protein-cleaving enzyme (BACE) for prevention, diagnosis and treatment of neurodegenerative and alzheimer's diseases |
| 01/08/2004 | US20040005688 Comprises dishevelled associated kinase (DAK) protein for diagnosis, prevention and treatment of cell proliferative diseases |
| 01/08/2004 | US20040005687 Kinase crystal structures |
| 01/08/2004 | US20040005686 Crystalline structure of human MAPKAP kinase-2 |
| 01/08/2004 | US20040005685 97316, a human amine oxidase family member and uses therefor |
| 01/08/2004 | US20040005684 Targeting proteins to deliver therapeutic or diagnostic reagents |
| 01/08/2004 | US20040005683 Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 01/08/2004 | US20040005678 Introducing into host microorganism a plurality of heterologous nucleic acid sequences, each coding for a different enzyme in the mevalonate pathway for producing isopentenyl pyrophosphate |
| 01/08/2004 | US20040005675 Nucleotide sequences encoding the ptsH gene |
| 01/08/2004 | US20040005672 Heterologous production of polyketides |
| 01/08/2004 | US20040005665 Comprises nucleotide sequences coding membrane proteins for diagnosing, preventing and treating inflammatory, tumorous and nervous system disorders |
| 01/08/2004 | US20040005664 Novel 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206 and 8843 molecules and uses therefor |
| 01/08/2004 | US20040005659 Comprises nucleotide sequences coding serine protease (PSS11-L) protein for diagnosing, treating and preventing osteoarthritic and bone disorders; gene therapy; gene expression inhibition; enzyme inhibitors |
| 01/08/2004 | US20040005655 Comprises nucleotides equences coding enzymatic polypeptides for destroying or detecting hydrogen peroxide and producing glyoxylic acid; bleaching; bactericide; papermaking |
| 01/08/2004 | US20040005654 Method of producing polyvalent antigens |
| 01/08/2004 | US20040005648 PYK2 related products and methods |
| 01/08/2004 | US20040005639 Glycerylaldehyde-3-phosphate dehyrogenase promoter inducing cell death |
| 01/08/2004 | US20040005626 Comprises nucleotide sequences coding membrane protein for diagnosing and treating inflammatory and tumor disorders |
| 01/08/2004 | US20040005624 84573, a human protein kinase family member and uses therefor |
| 01/08/2004 | US20040005604 Comprises nucleotide sequences coding enzymatic polypeptide for degumming oil and food processing; antisense therapy |
| 01/08/2004 | US20040005599 Heat resistant polymerase with improved accuracy in replication and amplification |
| 01/08/2004 | US20040005598 Comprises nucleotide sequences coding protein upregulated in metastatic prostate cancer (PUMPCn) for diagnosis and treatment of tumors; antiproliferative agents; anticarcinogenic agents |
| 01/08/2004 | US20040005597 Comprises nucleotide sequences coding chaperone protein which protects enzymes and cellular systems in extreme heat; polymerase chain reaction; preventing enzymatic aggregation and intracellular precipitation during heat stress |
| 01/08/2004 | US20040005594 Identifying and characterizing modulators of nucleic acid processing enzymes; enzyme inhibitors |